The activation of inflammatory signaling pathways such as NF-κB and NLRP3, and the release of ROS may be the main mechanism of TMAO's involvement in cardiovascular and cerebrovascular diseases (Liu et al., 2022, Praveenraj et al., 2022). The gene discussed is NLRP3; the disease is cerebrovascular disorder.